TECHNICAL FIELD
This invention is related to a remedy for a CAG repeat expansion disease.
BACKGROUND ART
Expansion of CAG trinucleotide repeats coding for polyglutamine stretches has been identified as a common pathogenic mutation for eight neurodegenerative diseases including spinal and bulbar
FIELD OF INVENTION
The present invention is directed to methods and compositions for treating diseases mediated by transglutaminase activity, by inhibiting the activity of transglutaminase.
BACKGROUND OF THE INVENTION
Protein cross-linking resulting in the formation of aggregates is a common feature